Blood transfusion prediction in patients undergoing major head and neck surgery with free-flap reconstruction

Archives of Otolaryngology - Head and Neck Surgery

Volumn 136, Issue 12, 2010, Pages 1199-1204

  Shah, Manish D ^a   Goldstein, David P ^a   McCluskey, Stuart A ^b   Miles, Brett A ^a   Hofer, Stefan ^b   Brown, Dale H ^a   Irish, Jonathan C ^a   Gullane, Patrick J ^a   Gilbert, Ralph W ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; BODY MASS; CANCER STAGING; CHILD; FEMALE; FREE TISSUE GRAFT; GENDER; HEAD AND NECK CANCER; HEAD AND NECK SURGERY; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREDICTION; RELIABILITY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SCORING SYSTEM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CHILD; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RECONSTRUCTIVE SURGICAL PROCEDURES; RETROSPECTIVE STUDIES; ROC CURVE; SURGICAL FLAPS; YOUNG ADULT;

EID: 78650807832     PISSN: 08864470     EISSN: 1538361X     Source Type: Journal    
DOI: 10.1001/archoto.2010.202     Document Type: Article

References (24)

1. Scott SN, Boeve TJ, McCulloch TM, Fitzpatrick KA, Karnell LH. The effects of epoetin alfa on transfusion requirements in head and neck cancer patients: a prospective, randomized, placebo-controlled study. Laryngoscope. 2002;112(7, pt 1):1221-1229.
2. Weber RS, Jabbour N, Martin RC II. Anemia and transfusions in patients undergoing surgery for cancer. Ann Surg Oncol. 2008;15(1):34-45.
3. Szakmany T, Dodd M, Dempsey GA, et al. The influence of allogenic blood transfusion in patients having free-flap primary surgery for oral and oropharyngeal squamous cell carcinoma. Br J Cancer. 2006;94(5):647-653.
4. Vamvakas EC, Blajchman MA. Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? Blood. 2001;97(5):1180-1195.
5. Schuller DE, Scott C, Wilson KM, et al. The effect of perioperative blood transfusion on survival in head and neck cancer. Arch Otolaryngol Head Neck Surg. 1994;120(7):711-716.
6. McCulloch TM, VanDaele DJ, Hillel A; The Department of Veterans Affairs Laryngeal Cancer Study Group. Blood transfusion as a risk factor for death in stage III and IV operative laryngeal cancer. Arch Otolaryngol Head Neck Surg. 1995;121(11):1227-1235.
7. Wong CJ, Vandervoort MK, Vandervoort SL, et al. A cluster-randomized controlled trial of a blood conservation algorithm in patients undergoing total hip joint arthroplasty. Transfusion. 2007;47(5):832-841.
8. Clark JR, McCluskey SA, Hall F, et al. Predictors of morbidity following free flap reconstruction for cancer of the head and neck. Head Neck. 2007;29(12):1090-1101.
9. Patel RS, McCluskey SA, Goldstein DP, et al. Clinicopathologic and therapeutic risk factors for perioperative complications and prolonged hospital stay in free flap reconstruction of the head and neck. Head Neck. 2010;32(10):1345-1353.
10. Kaplan MH, Feinstein AR. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chronic Dis. 1974;27(7-8):387-404.
11. Hall SF, Rochon PA, Streiner DL, Paszat LF, Groome PA, Rohland SL. Measuring comorbidity in patients with head and neck cancer. Laryngoscope. 2002;112(11):1988-1996.
12. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. Boca Raton, FL: CRC Press; 1998.
13. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15(4):361-387.
14. Weber RS. A model for predicting transfusion requirements in head and neck surgery. Laryngoscope. 1995;105(8, pt 2)(suppl 73):1-17.
15. Krupp NL, Weinstein G, Chalian A, Berlin JA, Wolf P, Weber RS. Validation of a transfusion prediction model in head and neck cancer surgery. Arch Otolaryngol Head Neck Surg. 2003;129(12):1297-1302.
16. Moir MS, Samy RN, Hanasono MM, Terris DJ. Autologous and heterologous blood transfusion in head and neck cancer surgery. Arch Otolaryngol Head Neck Surg. 1999;125(8):864-868. (Pubitemid 29372805)
17. Tretiak R, Laupacis A, Rivière M, McKerracher K, Souêtre E; Canadian Cost of Transfusion Study Group. Cost of allogeneic and autologous blood transfusion in Canada. CMAJ. 1996;154(10):1501-1508.
18. Nath A, Pogrel MA. Preoperative autologous blood donation for oral and maxillofacial surgery: an analysis of 913 patients. J Oral Maxillofac Surg. 2005;63(3):347-349. (Pubitemid 40269640)
19. Shaheen SP II, Lichtiger B. Autologous deposit of blood by oncology patients: an evaluation of actual use and wastage. Ann Surg Oncol. 1995;2(5):457-461.
20. Sturgis EM, Gianoli GJ, Miller RH, Fisher JW. Avoiding transfusion in head and neck surgery: feasibility study of erythropoietin. Laryngoscope. 2000;110(1):51-57.
21. Christopoulou M, Derartinian H, Hatzidimitriou G, Iatrou L. Autologous blood transfusion in oral and maxillofacial surgery patients with the use of erythropoietin. J Craniomaxillofac Surg. 2001;29(2):118-125. (Pubitemid 32427956)
22. Goodnough LT, Rudnick S, Price TH, et al. Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy. N Engl J Med. 1989;321(17):1163-1168.
23. Canadian Orthopedic Perioperative Erythropoietin Study Group. Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. Lancet. 1993;341(8855):1227-1232.
24. Karkouti K, McCluskey SA, Evans L, Mahomed N, Ghannam M, Davey R. Erythropoietin is an effective clinical modality for reducing RBC transfusion in joint surgery. Can J Anaesth. 2005;52(4):362-368.